Hussain I. Saba - Concepedia

Author

Hussain I. Saba

Also Known As

A Agastoni, HUSSAIN I. SABA, Hussain I Saba, Hussain I. Saba, Hussain I. Saba MD, PHD, Hussain I. Saba MD, PhD, Hussain Saba

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center James A. Haley Veterans' Hospital University of South Florida Florida College The University of Texas MD Anderson Cancer Center

About

Hussain I. Saba is an author at Moffitt Cancer Center specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	771
2	Cell Biology	3	3	71
3	Biochemistry	2	2	57
4	Public Health	1	1	63
5	Biomolecular Engineering	1	1	19

Hussain I. Saba

Publications

Citations

H-Index

Page 1

	Year	Citations
Decitabine improves patient outcomes in myelodysplastic syndromes Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld, Cancer	2006	1.5K
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia Hagop M. Kantarjian, Yasuhiro Oki, Guillermo Garcia‐Manero, Blood	2006	687
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes Lanlan Shen, Hagop M. Kantarjian, Yi Guo, Journal of Clinical Oncology	2009	355
Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma C. Wayne Cruse, Carmen Espinosa, Charles Cox, The American Journal of Surgery Surgical PathologyMelanomaLymphatic SystemSurgeryMalignant Melanoma	1991	242
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar) Ranjana H. Advani, Hussain I. Saba, Martin S. Tallman, Blood	1999	149
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar) Ranjana H. Advani, Hussain I. Saba, Martin S. Tallman, Blood	1999	123
Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes Mikkael A. Sekeres, Alan F. List, David Cuthbertson, Journal of Clinical Oncology	2010	110
Decitabine in the treatment of myelodysplastic syndromes. Hussain I. Saba PubMed Hematological MalignancyOncologyMyelodysplastic SyndromesMixed-phenotype Acute LeukemiaMds Patients	2007	97
Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia with Aminocaproic Acid Hussain I. Saba, Genevieve A. Morelli, Luis A. Logrono New England Journal of Medicine Aminocaproic AcidHematologyPathologyHemostasisCoagulopathy	1994	97
Heparin Neutralization of PGI <sub>2</sub> : Effects Upon Platelets Hussain I. Saba, Sabiha R. Saba, C Blackburn, Science	1979	68

Page 1